Goodwin advised Korro Bio on the deal.Korro Bio, Inc. announced its $116 million Series B financing. Korro is an RNA editing company focused on discovery and…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now